O
|
| Oatmeal baths |
|
 |
| for scabies |
|
 |
| for xerosis |
|
 |
|
| Obesity |
|
 |
| management of HTN |
|
 |
| post MI |
|
 |
| resources for |
|
 |
| screening (Table) |
|
 |
|
| Obsessive-compulsive disorder (OCD) |
|
 |
| antidepressants approved for |
|
 |
| benzodiazepine management of |
|
 |
| nonpharmacologic management of |
|
 |
|
| Obstruction |
|
 |
| bladder outlet |
|
 |
| classification |
|
 |
| evaluation of |
|
 |
| bowel |
|
 |
| renal (Table) |
|
 |
|
| Obstructive pulmonary disease, chronic (COPD) |
|
 |
| Chronic Obstructive Pulmonary Disease section |
|
 |
| with chronic productive cough and frequent exacerbation (Table) |
|
 |
| medications for (Table) |
|
 |
| preoperative risk assessment |
|
 |
| resources for |
|
 |
| therapy for (Table) |
|
 |
|
| Obstructive sleep apnea |
|
 |
|
| Occipital inflammation (Table) |
|
 |
|
| Occupational therapy (OT) |
|
 |
| for falls prevention |
|
 |
| for osteoarthritis |
|
 |
| for pain management |
|
 |
| for rheumatoid arthritis |
|
 |
|
| OCD (obsessive-compulsive disorder) |
|
 |
| antidepressants approved for |
|
 |
| benzodiazepine management of |
|
 |
| nonpharmacologic management of |
|
 |
|
| Octreotide (Sandostatin) |
|
 |
|
| Ocuflox Ophthalmic |
|
 |
| See also Ofloxacin |
|
 |
| prescribing information for acute bacterial conjunctivitis (Table) |
|
 |
|
| Ocupress |
|
 |
| See also Carteolol |
|
 |
| prescribing information for glaucoma (Table) |
|
 |
|
| Ocusert (pilocarpine gel) (Table) |
|
 |
|
| Ocuvite PreserVision |
|
 |
|
| Ofloxacin (Floxin, Ocuflox Ophthalmic, Roxin) |
|
 |
| prescribing information for acute bacterial conjunctivitis (Table) |
|
 |
| prescribing information for acute prostatitis |
|
 |
| prescribing information for chronic prostatits |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Ogen (estropipate) |
|
 |
| prescribing information for dyspareunia (Table) |
|
 |
| regimen for systemic hormone therapy (Table) |
|
 |
|
| Olanzapine (Zyprexa, Zydis) |
|
 |
| for acute mania |
|
 |
| for bipolar disorders (Table) |
|
 |
| daily dose thresholds (Table) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for agitation (Table) |
|
 |
| prescribing information for psychosis (Table) |
|
 |
| for psychotic disorders |
|
 |
| for SSRI-induced sexual dysfunction |
|
 |
|
| Olanzapine IM (Zyprexa Intramuscular) |
|
 |
| for delirium |
|
 |
| prescribing information for agitation (Table) |
|
 |
|
| Olmesartan (Benicar) |
|
 |
| with HCTZ (Benicar HCT) (Table) |
|
 |
| prescribing information for HTN (Table) |
|
 |
| target dose in HF (Table) |
|
 |
|
| Olopatadine (Patanol) (Table) |
|
 |
|
| Omacor |
|
 |
| See also Omega-3 fatty acids |
|
 |
| prescribing information for dyslipidemia (Table) |
|
 |
|
| Omalizumab (Xolair) (Table) |
|
 |
|
| Omega-3 fatty acids |
|
 |
| for MI, stroke prevention (Table) |
|
 |
| post MI |
|
 |
| prescribing information for dyslipidemia (Table) |
|
 |
|
| Omeprazole (Prilosec) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| enteral nutrition interactions |
|
 |
| prescribing information for GERD (Table) |
|
 |
| prescribing information for H pylori-induced ulcerations (Table) |
|
 |
|
| Omnicef (cefdinir) (Table) |
|
 |
|
| OMS Concentrate |
|
 |
| See also Morphine |
|
 |
| prescribing information for pain (Table) |
|
 |
|
| Ondansetron (Zofran) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for nausea and vomiting (Table) |
|
 |
| prescribing information for nausea and vomiting at end of life |
|
 |
|
| Onychomycosis |
|
 |
| Onychomycosis section |
|
 |
| topical antifungals for (Table) |
|
 |
|
| Opana (oxymorphone) (Table) |
|
 |
|
| Opioids |
|
 |
| with acetaminophen (Figure) |
|
 |
| for acute pain and short-term management |
|
 |
| analgesic drugs (Table) |
|
 |
| dosage |
|
 |
| management of adverse events |
|
 |
| for opioid-tolerant patients (Table) |
|
 |
| for osteoarthritis |
|
 |
| for pain at end of life |
|
 |
| for pain management |
|
 |
| for painful neuropathy |
|
 |
| for persistent pain (Table) |
|
 |
| prescribing information for dyspnea |
|
 |
| prescribing information for pain (Table) |
|
 |
| for restless legs syndrome |
|
 |
| risk of addiction |
|
 |
|
| Op-site |
|
 |
| See also Transparent film |
|
 |
| prescribing information for pressure ulcers (Table) |
|
 |
|
| Optical aids |
|
 |
|
| OptiPranolol (metipranolol) (Table) |
|
 |
|
| Optivar (azelastine) (Table) |
|
 |
|
| Oral nutrition |
|
 |
| lactose-free products (Table) |
|
 |
| for malnutrition |
|
 |
|
| Oral procedures: endocarditis prophylaxis for |
|
 |
| for dental patients with total joint replacements |
|
 |
| procedures warranting |
|
 |
| regimens (Table) |
|
 |
|
| Oral statements |
|
 |
|
| Oramorph SR (morphine) (Table) |
|
 |
|
| Orasone |
|
 |
| See also Prednisone |
|
 |
| prescribing information for adrenal insufficiency (Table) |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Orchiectomy |
|
 |
|
| Orencia (abatacept) |
|
 |
|
| Oretic (HCTZ) (Table) |
|
 |
|
| Orgaran (danaparoid) (Table) |
|
 |
|
| Ortho-Est |
|
 |
| See also Estropipate |
|
 |
| regimen for systemic hormone therapy (Table) |
|
 |
|
| Orthostatic (postural) hypotension |
|
 |
| Orthostatic (Postural) Hypotension section |
|
 |
| corticosteroids for (Table) |
|
 |
| distinguishing early Parkinson's disease from other parkinsonian syndromes (Table) |
|
 |
| dizziness in |
|
 |
| drug-induced (Table) |
|
 |
| preventing falls with (Table) |
|
 |
|
| Orthostatic syncope |
|
 |
| classification of (Table) |
|
 |
| evaluation of |
|
 |
| management of |
|
 |
|
| Orthotics |
|
 |
| for diabetic foot ulcers |
|
 |
| for plantar fasciitis |
|
 |
| for rheumatoid arthritis |
|
 |
| for trochanteric bursitis |
|
 |
| for venous ulcers |
|
 |
|
| Orthovisc (hyaluronic acid) |
|
 |
|
| Orudis (ketoprofen) (Table) |
|
 |
|
| Oruvail (ketoprofen) (Table) |
|
 |
|
| Osbon-Erec Aid (vacuum tumescence device) (Table) |
|
 |
|
| Oseltamivir (Tamiflu) (Table) |
|
 |
|
| Osmolality |
|
 |
| calculated |
|
 |
| in hyponatremia |
|
 |
|
| Osmolite (Table) |
|
 |
|
| Osteoarthritis |
|
 |
| Osteoarthritis section |
|
 |
| APAP and NSAIDs for (Table) |
|
 |
| in back |
|
 |
| and falls (Table) |
|
 |
| in hip |
|
 |
| in knee |
|
 |
| pain relief (Table) |
|
 |
| pharmacologic management (Figure) |
|
 |
| resources for |
|
 |
|
| Osteocalcin |
|
 |
| See also Calcitonin |
|
 |
| prescribing information for osteoporosis |
|
 |
|
| Osteomyelitis |
|
 |
| chronic wound treatment |
|
 |
| diabetic foot ulcers |
|
 |
| surgical intervention |
|
 |
|
| Osteonecrosis (Table) |
|
 |
|
| Osteoporosis |
|
 |
| Osteoporosis chapter |
|
 |
| antihypertensive therapy and (Table) |
|
 |
| bone outcomes of medications for (Table) |
|
 |
| effects on other outcomes, level of evidence, and risks of medications for (Table) |
|
 |
| prophylaxis for (Table) |
|
 |
| resources for |
|
 |
|
| OT (occupational therapy) |
|
 |
| for falls prevention |
|
 |
| for osteoarthritis |
|
 |
| for pain management |
|
 |
| for rheumatoid arthritis |
|
 |
|
| Ovarian cancer |
|
 |
|
| Overflow incontinence |
|
 |
| See also Urinary incontinence |
|
 |
| classification of |
|
 |
|
| Oxacillin (Bactocill) (Table) |
|
 |
|
| Oxaprozin (Daypro) (Table) |
|
 |
|
| Oxazepam (Serax) |
|
 |
| daily dose thresholds (Table) |
|
 |
| prescribing information for anxiety (Table) |
|
 |
|
| Oxcarbazepine (Trileptal) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Oxy IR (oxycodone) (Table) |
|
 |
|
| Oxybutynin (Ditropan, Ditropan XL, Oxytrol) |
|
 |
| and dementia |
|
 |
| prescribing information for UI (Table) |
|
 |
|
| Oxycodone (Oxy IR, Roxicodone) |
|
 |
| with APAP (Percocet, Tylox) (Table) |
|
 |
| with ASA (Percodan) (Table) |
|
 |
| extended release (OxyContin) (Table) |
|
 |
| prescribing information for pain (Table) |
|
 |
|
| OxyContin (oxycodone) (Table) |
|
 |
|
| Oxygen |
|
 |
| alveolar-arterial oxygen gradient |
|
 |
| partial pressure of, arterial (Pao2) |
|
 |
|
| Oxygen therapy |
|
 |
| for acute MI |
|
 |
| for dyspnea |
|
 |
| long-term |
|
 |
| for COPD |
|
 |
| indications for (Table) |
|
 |
| for severe COPD (Table) |
|
 |
| for pneumonia |
|
 |
|
| Oxymetazalone (Afrin) (Table) |
|
 |
|
| Oxymorphone (Opana) (Table) |
|
 |
|
| Oxytrol |
|
 |
| See also Oxybutynin |
|
 |
| prescribing information for UI (Table) |
|
 |
If a subject is not in the index, use the search box to search the site.
The results will be displayed in the order they appear in the site,
with the option to page back and forth through lists of multiple results.
Words are case and order insensitive, and all characters will be used in a search.
Note: The search terms will not be highlighted in the result pages. Use your browser's "Find (on This Page)" and "Find Again" functions to locate specific term occurrences within result pages.